Breakthrough Triple Vaccine Targets Coronavirus, Flu, and RSV: Revolutionizing Respiratory Pandemic Protection
Researchers have announced the development of a tripartite vaccine targeting three major respiratory viruses—SARS-CoV-2, influenza, and respiratory syncytial virus (RSV)—with early trials showing “promising preliminary results.” The vaccine represents a potential breakthrough in reducing the burden of respiratory illnesses. The project aims to address the overlapping threats of viral respiratory diseases. This approach could simplify … Read more
